Topiramate-induced restless legs syndrome: A report of two cases [3]

Journal of Neurology

Volumn 254, Issue 8, 2007, Pages 1120-1121

  Romigi, Andrea ^a   Izzi, Francesca ^a   Placidi, Fabio ^a   Sperli, Francesca ^a   Cervellino, Angela ^a   Marciani, Maria Grazia ^a,b  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CARBAMAZEPINE; ELECTROLYTE; FERRITIN; IRON; PHENOBARBITAL; PHENYTOIN; THYROID HORMONE; TOPIRAMATE;

ADULT; BLOOD ANALYSIS; CASE REPORT; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HORMONE DETERMINATION; HUMAN; KIDNEY FUNCTION; LETTER; LIMB DISEASE; LIMB MOVEMENT; LIVER FUNCTION TEST; NEUROPHYSIOLOGY; PERIODIC LIMB MOVEMENT IN SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REMISSION; RESTLESS LEGS SYNDROME; SYMPTOMATIC EPILEPSY; TRAUMATIC EPILEPSY; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME;

EID: 34548438062     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0243-z     Document Type: Letter

References (11)

1. Lesage S Hening WA (2004) The restless legs syndrome and periodic limb movement disorder: a review of management. Sem Neurol 24:249-259
2. Thorpy MJ (2005) New paradigms in the treatment of restless legs syndrome. Neurology 64 (Suppl 3):S28-S33
3. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. (2004) Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-relase levodopa/benserazide. J Neurol; 251:579-583
4. Youssef EA, Wagner ML, Martinez JO, Hening W. (2005) Pilot trial of lamotrigine in restless legs syndrome. Sleep Med 6(1):89
5. Chen JT, Garcia PA, Alldredge BK (2003) Zonisamide-induced restless legs syndrome. Neurology 14:60(1):147
6. The International Restless Legs Syndrome Study Group (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4:121-132
7. Silberstein SD, Ben-Menachem E, Shank RP Wiegand F (2005) Topiramate monotherapy in epilepsy and migraine prevention. Clin Therapeut 27:154-165
8. Schank RP, Gardocki JF, Streeter AJ, Maryanoff BE (2000) An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action. Epilepsia 41(Suppl 1):S3-S9
9. Johnson BA (2004) Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence? Addict Behav 29:1465-1479
10. Schiffer WK, Gerasimov MR, Marsteller DA, Geiger J, Barnett C, Alexoff DL, Dewey SL (2001) Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 42:196-198
11. Stiasny-Kolster K, Trenkwalder C, Fogel W, Greulich W, Hahne M, Lachenmayer L, Oechsner W, Oertel H. (2004) Restless legs syndrome-new insights into clinical characteristics, pathophysiology, and treatment options. J Neurol 251:S39-43